RNASEH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.198600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.200000E-01
Normal-vs-Stage2
7.283000E-01
Normal-vs-Stage3
2.998200E-01
Normal-vs-Stage4
4.342800E-01
Stage1-vs-Stage2
4.368000E-01
Stage1-vs-Stage3
2.991000E-01
Stage1-vs-Stage4
2.288000E-01
Stage2-vs-Stage3
9.602400E-02
Stage2-vs-Stage4
4.214800E-01
Stage3-vs-Stage4
1.025000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.187200E-01
Normal-vs-AfricanAmerican
7.968200E-01
Normal-vs-Asian
9.923600E-01
Caucasian-vs-AfricanAmerican
9.564200E-01
Caucasian-vs-Asian
6.544600E-01
AfricanAmerican-vs-Asian
7.050400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.952200E-01
Normal-vs-Female
8.482800E-01
Male-vs-Female
7.832200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.906000E-01
Normal-vs-Age(41-60Yrs)
5.600600E-01
Normal-vs-Age(61-80Yrs)
9.910600E-01
Normal-vs-Age(81-100Yrs)
5.368200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.356600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.729400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.593000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.956000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.576200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.332800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.776800E-01
Normal-vs-Daily Drinker
8.187800E-01
Normal-vs-Weekly Drinker
7.133800E-01
Normal-vs-Occasional Drinker
5.932800E-01
Normal-vs-Social Drinker
5.246200E-01
Non Drinker-vs-Daily Drinker
4.053600E-01
Non Drinker-vs-Weekly Drinker
5.229000E-01
Non Drinker-vs-Occasional Drinker
4.689400E-01
Non Drinker-vs-Social Drinker
3.432200E-01
Daily Drinker-vs-Weekly Drinker
2.702200E-01
Daily Drinker-vs-Occasional Drinker
1.770030E-01
Daily Drinker-vs-Social Drinker
1.408560E-01
Weekly Drinker-vs-Occasional Drinker
9.335600E-01
Weekly Drinker-vs-Social Drinker
9.077600E-01
Occasional Drinker-vs-Social Drinker
7.853600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.693000E-01
Normal-vs-Grade 2
7.954600E-01
Normal-vs-Grade 3
6.928000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.124100E-03
Grade 1-vs-Grade 3
2.211600E-04
Grade 1-vs-Grade 4
9.693000E-01
Grade 2-vs-Grade 3
4.814400E-02
Grade 2-vs-Grade 4
7.954600E-01
Grade 3-vs-Grade 4
6.928000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.129800E-01
Normal-vs-NonDiabetic
9.588400E-01
Diabetic-vs-NonDiabetic
5.104200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.671600E-01
Normal-vs-NoPancreatitis
8.916200E-01
Pancreatitis-vs-NoPancreatitis
6.216200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.045200E-01
Normal-vs-N1
7.773200E-01
N0-vs-N1
8.557200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.867000E-01
Normal-vs-TP53-NonMutant
9.020200E-01
TP53-Mutant-vs-TP53-NonMutant
9.356600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
